All News

The FDA has approved evolocumab (Repatha, Amgen) for the prevention of heart attacks, stroke, and coronary revascularizations in adult patients with already established cardiovascular disease.

FDA officials have approved the first once-monthly buprenorphine injectable product, Sublocade (Indivior), for the treatment of moderate-to-severe opioid use disorder (OUD).

FDA officials have issued a warning regarding the risks associated with kratom use.

Updated hypertension guidelines set a new definition for high blood pressure, lowering the threshold for hypertension.

Officials with the FDA have approved the supplemental new drug application (sNDA) for cariprazine (Vraylar, Allergan) for use in adults for the maintenance treatment of schizophrenia.

Fentanyl was detected in more than half of opioid overdose deaths in 10 states during the second half of 2016, according to data published in CDC’s Morbidity and Mortality Weekly Report (MMWR) Early Release.

Treating patients who have acute illnesses like rash, bronchitis, and urinary tract infection is more cost-effective when they see health care providers in urgent care clinics or retail health care locations.

In 2 unanimous votes, the Advisory Committee on Immunization Practices (ACIP) agreed to recommended revisions in the 2018 adult and child/adolescent immunization schedules.

In a narrow 8-7 vote, the Advisory Committee on Immunization Practices (ACIP) endorsed the use of the newly FDA approved zoster vaccine recombinant, adjuvanted (Shingrix, GlaxoSmithKline) over the established zoster vaccine live (Zostavax, Merck).

Patients with cancer who experienced a heart attack were more likely to die in the hospital compared with patients without cancer, according to the study.

Glenmark’s current portfolio consists of 127 products authorized for distribution in the US marketplace and 60 new drug applications pending approval with the FDA.

Nurse practitioners (NPs) who work in supportive environments are more likely to have their own patient panels than those who work in less supportive environments.

Almost all health care professionals face a series of questions when they apply or reapply for their professional licenses.

Officials with the FDA launched a new search that enables better access to information on adverse drug events associated with drug and biologic products through the FDA’s Adverse Event Reporting System (FAERS).

Officials with the FDA have approved the first continuous glucose monitoring system that allows individuals to make diabetes treatment decisions without using a blood sample from the fingertip.

Sexually transmitted disease (STDs) cases have hit record numbers in the United States, according to the CDC's annual Sexually Transmitted Disease Report. According to the report, more than 2 million STD cases were reported in 2016.

Opioid-related problems, such as adverse reactions and opioid dependency, are increasing among children in the United States, according to 2 study abstracts presented at the recent American Academy of Pediatrics 2017 National Conference in Chicago.

Role expansion is a hot topic for nurse practitioners and physicians assistants as health care policymakers increasingly appreciate their value in health care.

Officials with the FDA have approved an extended-release amphetamine (Adzenys ER, Neos Therapeutics) oral suspension for the treatment of attention-deficit hyperactivity disorder (ADHD).

The words “heart failure” (HF) are generally modified by a list of depressing adjectives: chronic, progressive, and debilitating. In the United States, more than 5.8 million people have active HF diagnoses.

The ADA's recommendations, which include a newly added pictorial algorithm for the treatment of confirmed hypertension in people with diabetes, are featured in the the September issue of Diabetes Care.

The results of the study showed that after both strains infected the tumors, the virus killed the cancer stem cells and left other tumor cells alone.

Missing doses of necessary drugs can result in disease progression and poor health outcomes, according to the AARP.

Several health groups have written a petition requesting that the FDA remove ultra-high dosage unit (UHDU) analgesics from the market.

The US FDA has granted a "breakthrough therapy" designation to 3,4-methylenedioxymethamphetamine (MDMA), also known as the street-drug ecstasy, for the treatment of posttraumatic stress disorder (PTSD).

Officials with the FDA have approved a new indication for liraglutide (Victoza, Novo Nordisk), according to a press release from Novo. The updated indication makes Victoza the only type 2 diabetes drug indicated to reduce the risk of major adverse cardiovascular events.

Officials with the CDC have published recommendations from the Advisory Committee on Immunization Practices (ACIP) for the prevention and control of seasonal influenza with vaccines for the 2017-2018 season.

Epilepsy rates among Americans have been increasing, according to data reported in the CDC's Morbidity and Mortality Weekly Report.

The FDA has approved a novel fixed-dose combination therapy indicated to treat hyperuricemia in patients with uncontrolled gout.

The results of a recent survey suggest Americans are increasingly likely to receive their flu vaccination this year.